Nephros - 21 Year Stock Price History | NEPH
Historical daily share price chart and data for Nephros since 2004 adjusted for splits and dividends. The latest closing stock price for Nephros as of November 17, 2025 is 5.43.
- The all-time high Nephros stock closing price was 1053.00 on September 21, 2004.
- The Nephros 52-week high stock price is 5.98, which is 10.1% above the current share price.
- The Nephros 52-week low stock price is 1.39, which is 74.4% below the current share price.
- The average Nephros stock price for the last 52 weeks is 2.93.
| Nephros Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2025 | 3.1108 | 1.4600 | 5.7400 | 1.4100 | 5.4300 | 269.39% |
| 2024 | 2.1958 | 3.4300 | 3.7800 | 1.3643 | 1.4700 | -57.51% |
| 2023 | 1.5681 | 1.1100 | 3.9050 | 0.9701 | 3.4600 | 199.00% |
| 2022 | 2.4739 | 6.1200 | 6.1200 | 0.9100 | 1.1572 | -80.39% |
| 2021 | 8.0519 | 7.9599 | 10.6800 | 5.8700 | 5.9000 | -31.24% |
| 2020 | 7.6091 | 9.3087 | 10.2900 | 5.5800 | 8.5800 | -13.77% |
| 2019 | 6.4885 | 5.3100 | 11.3500 | 4.0491 | 9.9500 | 93.96% |
| 2018 | 5.1142 | 4.0500 | 6.3450 | 3.4227 | 5.1300 | 26.64% |
| 2017 | 3.2510 | 3.7800 | 5.3991 | 1.8900 | 4.0509 | 22.94% |
| 2016 | 2.9817 | 2.9700 | 4.9500 | 2.2500 | 3.2949 | 69.93% |
| 2015 | 5.1721 | 7.3341 | 8.6400 | 1.9390 | 1.9390 | -72.73% |
| 2014 | 6.7883 | 3.6000 | 10.8000 | 2.9250 | 7.1100 | 86.32% |
| 2013 | 8.6785 | 10.8000 | 15.2100 | 2.9700 | 3.8160 | -64.37% |
| 2012 | 12.4210 | 6.2100 | 27.3600 | 6.1650 | 10.7100 | 72.46% |
| 2011 | 10.2751 | 19.8000 | 21.6000 | 2.7000 | 6.2100 | -65.50% |
| 2010 | 89.1582 | 153.0000 | 216.0000 | 14.4000 | 18.0000 | -87.18% |
| 2009 | 153.3855 | 25.2000 | 455.4000 | 4.5000 | 140.4000 | 555.46% |
| 2008 | 94.2539 | 86.3999 | 252.0000 | 10.8000 | 21.4200 | -76.20% |
| 2007 | 239.3539 | 271.8000 | 441.0000 | 89.9999 | 89.9999 | -65.52% |
| 2006 | 290.2350 | 260.9820 | 520.2000 | 172.8000 | 261.0000 | 0.69% |
| 2005 | 581.0200 | 860.3990 | 1029.6000 | 239.4000 | 259.2000 | -69.62% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.047B | $0.014B |
| Nephros develops advanced End Stage Renal Disease, or ESRD, therapy technology and products that would address both patient treatment needs and the clinical and financial needs of the treatment provider. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $227.079B | 26.17 |
| EssilorLuxottica (ESLOY) | France | $171.331B | 0.00 |
| Boston Scientific (BSX) | United States | $152.232B | 34.81 |
| Stryker (SYK) | United States | $138.522B | 27.50 |
| Medtronic (MDT) | Ireland | $122.971B | 17.34 |
| Lonza Group Ag (LZAGY) | Switzerland | $48.219B | 0.00 |
| Agilent Technologies (A) | United States | $41.624B | 26.94 |
| ResMed (RMD) | United States | $35.677B | 24.69 |
| GE HealthCare Technologies (GEHC) | United States | $33.321B | 15.94 |
| Koninklijke Philips (PHG) | Netherlands | $27.607B | 18.03 |
| Insulet (PODD) | United States | $23.404B | 72.64 |
| Terumo (TRUMY) | Japan | $22.638B | 25.48 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.819B | 11.11 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.952B | 0.00 |
| Baxter (BAX) | United States | $9.495B | 7.66 |
| Sunny Optical Technology (SNPTF) | China | $9.361B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.447B | 30.37 |
| Demant (WILYY) | Denmark | $7.346B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $3.515B | 10.71 |
| Haemonetics (HAE) | United States | $3.440B | 15.31 |
| ICU Medical (ICUI) | United States | $3.370B | 21.40 |
| Envista Holdings (NVST) | United States | $3.190B | 18.30 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.120B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $2.886B | 13.16 |
| LeMaitre Vascular (LMAT) | United States | $2.006B | 40.38 |
| Perrigo (PRGO) | Ireland | $1.896B | 4.75 |
| Phibro Animal Health (PAHC) | United States | $1.828B | 18.26 |
| AtriCure (ATRC) | United States | $1.636B | 0.00 |
| QuidelOrtho (QDEL) | United States | $1.450B | 9.32 |
| Neogen (NEOG) | United States | $1.389B | 26.62 |
| Curaleaf Holdings (CURLF) | Canada | $1.385B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $1.287B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.245B | 18.02 |
| Tilray Brands (TLRY) | Canada | $1.213B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.195B | 52.36 |
| BioLife Solutions (BLFS) | United States | $1.159B | 343.86 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.931B | 0.00 |
| InMode (INMD) | Israel | $0.896B | 10.12 |
| Valneva SE (VALN) | France | $0.778B | 0.00 |
| Surmodics (SRDX) | United States | $0.595B | 0.00 |
| Omeros (OMER) | United States | $0.558B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.495B | 17.03 |
| CeriBell (CBLL) | United States | $0.479B | 0.00 |
| Evolus (EOLS) | United States | $0.468B | 0.00 |
| SNDL (SNDL) | Canada | $0.441B | 0.00 |
| BillionToOne (BLLN) | $0.402B | 0.00 | |
| Cresco Labs (CRLBF) | United States | $0.344B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.340B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| Cerus (CERS) | United States | $0.311B | 0.00 |
| Brainsway (BWAY) | Israel | $0.308B | 52.53 |
| Sanuwave Health (SNWV) | United States | $0.283B | 0.00 |
| Quanterix (QTRX) | United States | $0.268B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.257B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.256B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.244B | 143.67 |
| Viemed Healthcare (VMD) | United States | $0.243B | 19.36 |
| High Tide (HITI) | Canada | $0.236B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.227B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| Exagen (XGN) | United States | $0.204B | 0.00 |
| Organigram Global (OGI) | Canada | $0.204B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.192B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.178B | 15.64 |
| FitLife Brands (FTLF) | United States | $0.170B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.166B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.157B | 0.00 |
| Apyx Medical (APYX) | United States | $0.149B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.126B | 0.00 |
| Biote (BTMD) | United States | $0.115B | 5.04 |
| Quipt Home Medical (QIPT) | United States | $0.100B | 0.00 |
| MacroGenics (MGNX) | United States | $0.095B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.093B | 0.00 |
| Fonar (FONR) | United States | $0.091B | 13.25 |
| Sharps Technology (STSS) | United States | $0.087B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.081B | 0.00 |
| Agape ATP (ATPC) | $0.067B | 0.00 | |
| ImmuCell (ICCC) | United States | $0.049B | 20.77 |
| Cytosorbents (CTSO) | United States | $0.041B | 0.00 |
| Jin Medical (ZJYL) | China | $0.040B | 0.00 |
| Veru (VERU) | United States | $0.037B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.036B | 0.00 |
| Modular Medical (MODD) | United States | $0.029B | 0.00 |
| Bonk (BNKK) | United States | $0.029B | 0.00 |
| United-Guardian (UG) | United States | $0.028B | 14.30 |
| Zynex (ZYXI) | United States | $0.017B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.012B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.012B | 0.00 |
| INLIF (INLF) | China | $0.010B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.008B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Flora Growth (FLGC) | United States | $0.006B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.005B | 0.00 |
| Functional Brands (MEHA) | $0.003B | 0.00 | |
| Akanda (AKAN) | Canada | $0.001B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |